Horizon Technology Finance Corp. (HRZN) - Q2 2026 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended June 30, 2026. Horizon Technology Finance Corporation (HRZN) is an externally managed, closed-end, non-diversified business development company (BDC) regulated under the 1940 Act. The company primarily makes secured debt investments in development-stage companies within the technology, life science, healthcare information and services, and sustainability sectors.
A material event during the period was the completion of the merger with Monroe Capital Corporation (MRCC) on April 14, 2026. The transaction was accounted for as an asset acquisition, resulting in the issuance of approximately 20.4 million shares of common stock and the receipt of approximately $141.3 million in cash. Transaction costs of $4.4 million were recorded as merger expenses.
Key Financial Metrics
| Metric | Q2 2026 (Three Months) | Q2 2025 (Three Months) | YTD 2026 (Six Months) | YTD 2025 (Six Months) |
|---|---|---|---|---|
| Total Investment Income | $25.0 million | $24.5 million | $49.1 million | $49.0 million |
| Total Expenses | $17.4 million | $12.7 million | $32.2 million | $26.1 million |
| Net Investment Income | $7.4 million | $11.4 million | $16.4 million | $22.2 million |
| Net Realized Loss | $(6.1) million | $(10.1) million | $(7.7) million | $(10.1) million |
| Net Unrealized Depreciation | $(38.5) million | $(22.2) million | $(43.1) million | $(54.3) million |
| Net Decrease in Net Assets | $(37.3) million | $(20.8) million | $(34.5) million | $(42.2) million |
| Net Asset Value (NAV) per Share | $6.23 | $6.98 (Dec 31, 2025) | $6.23 | $6.75 (Jun 30, 2025) |
| Total Borrowings Outstanding | $402.4 million | $473.0 million (Dec 31, 2025) | $402.4 million | $473.0 million (Dec 31, 2025) |
| Cash and Cash Equivalents | $132.3 million | $140.2 million (Dec 31, 2025) | $132.3 million | $140.2 million (Dec 31, 2025) |
Material Changes vs. Prior Period
- Merger Impact: The completion of the MRCC merger significantly altered the capital structure, increasing shares outstanding from ~45.6 million to ~67.0 million. Merger-related expenses of $4.4 million were incurred in Q2 2026, contributing to the increase in total expenses compared to Q2 2025.
- Expense Fluctuation: Total expenses increased by 36.9% in Q2 2026 compared to Q2 2025, primarily driven by the one-time merger costs. Excluding merger expenses, operating expenses remained relatively stable.
- Unrealized Depreciation: Net unrealized depreciation on investments was $38.5 million for Q2 2026, an increase from $22.2 million in Q2 2025. This was primarily due to unrealized depreciation on specific equity and debt investments, partially offset by reversals from settled investments.
- Debt Management: The company redeemed all outstanding 2026 Notes ($57.5 million) in January 2026. Additionally, $15.1 million of 2030 Convertible Notes were converted into common stock during the six months ended June 30, 2026.
- Portfolio Composition: As of June 30, 2026, the portfolio consisted of 95.8% debt investments, 2.5% warrants, 1.1% equity, and 0.6% other investments. The weighted average credit rating of the debt portfolio was 2.3 on the updated 1-to-5 scale.
Guidance, Outlook, and Risks
- Fee Waiver: In connection with the merger, the Advisor agreed to waive $4.0 million of base management and/or incentive fees at a rate of $1.0 million per quarter, commencing with Q3 2026 and ending in Q2 2027.
- Stock Repurchase Program: The Board extended the stock repurchase program on May 1, 2026, authorizing up to $10.0 million in repurchases. During Q2 2026, the company repurchased 1.37 million shares at an average price of $4.54. On August 3, 2026, the Board approved an increase in the program to allow repurchases up to a total of $20.0 million.
- Distributions: The Board declared regular monthly distributions of $0.06 per share and special monthly distributions of $0.03 per share for September, October, and November 2026. As of June 30, 2026, the company had undistributed spillover income of $0.33 per share.
- Risks: The filing highlights risks related to geopolitical conflicts in the Middle East, potential inflationary pressures, and the difficulty of the equity fundraising market for portfolio companies. The company also notes that 99% of its debt investments bear floating interest rates, exposing it to interest rate risk.
- Joint Venture: The company formed the RoHo Capital Opportunity Fund LLC (RoHo Joint Venture) with CR Financial Holdings, Inc. in March 2026. As of June 30, 2026, no investments had been made by the joint venture.
Key Facts for Investor Verification
- Merger Accounting: Verify the treatment of the MRCC merger as an asset acquisition and the impact on the cost basis of the acquired portfolio for tax purposes.
- Credit Quality Deterioration: Review the increase in investments rated 4 or 5 (deteriorating credit quality) from 13.1% of the portfolio at Dec 31, 2025, to 12.3% at June 30, 2026, and the specific portfolio companies driving this change.
- Non-Accrual Status: Confirm the status of the four debt investments on non-accrual status as of June 30, 2026, which had an aggregate cost of $57.0 million and fair value of $31.3 million.
- Fee Waiver Execution: Monitor the execution of the $4.0 million fee waiver starting in Q3 2026 and its impact on future net investment income.
- Convertible Note Conversions: Track the conversion of 2030 and 2031 Convertible Notes into common stock and the resulting dilution or accretion to NAV.